Sally Clive
Vice President for Healthcare Outcomes Policy and
Oncology and Molecular Radiation Sciences
University of Edinburgh
Norway
Biography
Dr Clive works as a consultant in medical oncology in the Edinburgh Cancer Centre and in Fife, specialising in the medical management of colorectal cancer, cancers of unknown primary and early phase clinical trials. Sally has been chief investigator, principal investigator and co-investigator on numerous clinical trials over her career and works closely with medical colleagues in the Edinburgh Cancer Centre, the clinical trials team and the ECMC to deliver high quality trials with robust data and specimen collection. She has collaborated with colleagues across the UK and beyond on multicentre clinical trials (phase I-IV) with the overarching desire to make meaningful improvement to patient outcomes.
Research Interest
Sally has been chief investigator in first-in-man phase I clinical trials and pharmacokinetic organ function, drug interaction and ADME trials and is currently running a study investigating the cardiotoxicity of oral fluoropyrimidines. Her research interests are early phase clinical trials, clinical research in colorectal cancer, improving outcomes for patients with mCUP and investigating the toxicities associated with chemotherapy.
